In Part Three of his "How to Win 2026" series, Newt Gingrich tackles the two hardest arguments in the entire 2026 campaign: the economy and Iran. On affordability, Newt makes the Republican case with specific facts and dollar figures: the steepest drop in prescription drug prices in sixty years, GLP-1 medications now available for $149 a month through TrumpRx, $82 billion in individual tax relief claimed in a single filing season, and concrete steps already underway on housing, energy, and regulation. On Iran, Newt is equally direct — the war has not gone as planned, the Iranian regime has proven more determined than expected, and there is no easy exit. But backing down, he argues, means gambling that a regime chanting "death to America" won't eventually make good on it.
Explore How to Win 2026
The 2026 midterms could be a defining moment for America. Follow Newt Gingrich and Gingrich 360’s latest columns and analysis on the ideas, policies, and strategies Republicans need to win the big arguments, grow the American majority, and deliver real results for the American people.
How to Win 2026 is part of a larger effort to identify the ideas, policies, and arguments that can create a lasting American majority.
Explore our latest columns, research, commentary, and analysis on the Republican Opportunity in 2026.
